Category: Cardiovascular
Global Cardiovascular
-
Global Decentralised Clinical Trials Market Size Study, by Study Design (Interventional, Observational, Expanded Access), by Indication (Oncology, Cardiovascular, Immunology, Respiratory, Others), by Component (Mobile Healthcare, Telemedicine, Wearable Devices, Web-based Technology, Others), by End-users (Pharmaceutical and Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032
... Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032 Global Decentralised Clinical Trials Market is valued at approximately USD 9.30 billion in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global Statin Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Cholesterol Testing
... at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$11.6 Billion by the end ... Read More
-
Acute Heart Failure (AHF) Therapeutics
... is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 21.3% over the analysis period 2023-2030. Cardiac Glycosides, one of the segments analyzed in the report, is expected to record a 21.8% ... Read More
-
Atrial Fibrillation Devices
... by 2030, growing at a CAGR of 12.2% over the analysis period 2023-2030. EP Ablation Catheters, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$4.8 Billion ... Read More
-
Cardiovascular Catheters
... at a CAGR of 6.5% over the analysis period 2023-2030. Cardiovascular Therapeutic Catheters, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$25.4 Billion by the end ... Read More
-
Acute Coronary Syndrome
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 16.4% CAGR The Acute Coronary Syndrome market ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% ... Read More
-
Dyslipidemia - Global Clinical Trials Review, 2024
... report provides top line data relating to the clinical trials on Dyslipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of ... Read More
-
Minimally Invasive Surgical Instruments Market by Product (Handheld, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestional, Bariatric, Orthopedic, Urological), Technology (Non-robotic, Robotic) - Global Forecast to 2029
... projected to reach USD 49.9 Billion by 2029 from USD 31.7 Billion in 2024, at a CAGR of 9.5% during the forecast period. Market expansion is propelled by factors such as the growing utilization of ... Read More
-
2024 Global: Myocardial Fibrosis Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Global Atherosclerosis Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Cardiovascular Catheters Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Transdermal Drug Delivery System Market by Type (Transdermal Patches, Transdermal Semisolids), Application (Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications), End User - Global Forecast 2024-2030
... at USD 6.98 billion in 2023 and expected to reach USD 7.32 billion in 2024, at a CAGR 5.06% to reach USD 9.87 billion by 2030. Transdermal drug delivery comprises the production, distribution, and application ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 23.02 billion in 2023 and expected to reach USD 28.35 billion in 2024, at a CAGR 23.76% to reach USD 102.40 billion by 2030. Regenerative medicine is an interdisciplinary field that applies engineering and ... Read More
-
Medical Laser System Market by Product (Diode Lasers Systems, Dye Lasers Systems, Gas Lasers), Application (Cardiovascular, Dentistry, Dermatology), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 6.41 billion in 2024, at a CAGR 13.23% to reach USD 13.52 billion by 2030. Medical laser systems refer to devices that utilize focused light sources to apply ... Read More
-
Artificial Intelligence in Medical Diagnostics Market by Component (Hardware, Services, Software), Technology (Computer Vision, Machine Learning Platforms, Natural Language Processing), Application, End-User - Global Forecast 2024-2030
... estimated at USD 1.00 billion in 2023 and expected to reach USD 1.16 billion in 2024, at a CAGR 17.23% to reach USD 3.04 billion by 2030. Artificial intelligence (AI) in the medical diagnostics market ... Read More
-
Cell & Gene Therapy Manufacturing Services Market by Type (Cell Therapy, Gene Therapy), Indication (Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases), Application, End-User - Global Forecast 2024-2030
... Market size was estimated at USD 17.34 billion in 2023 and expected to reach USD 19.98 billion in 2024, at a CAGR 15.81% to reach USD 48.45 billion by 2030. Cell and gene therapy manufacturing ... Read More
-
Cardiac Marker Market by Product (Instruments, Reagents & Kits), Biomarker Type (BNP Or NT-ProBNP, CK-MB, Hs-CRP), End-User, Indication - Global Forecast 2024-2030
... and expected to reach USD 4.16 billion in 2024, at a CAGR 9.71% to reach USD 7.29 billion by 2030. Cardiac markers are substances or molecules measured in the blood to diagnose and monitor various ... Read More
-
Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.98 billion in 2024, at a CAGR 13.63% to reach USD 8.59 billion by 2030. Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into ... Read More
-
Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Global Forecast 2024-2030
... 5.10 billion in 2023 and expected to reach USD 5.50 billion in 2024, at a CAGR 7.90% to reach USD 8.69 billion by 2030. Cardiac marker testing market consists of the spectrum of medical technologies ... Read More
-
Global Active Pharmaceutical Ingredients (API) Market Report by Drug Type (Innovative, Generic), Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Application (Cardiovascular Diseases, Oncology, Central Nervous System and Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Other Applications), Regions and Company Analysis 2024-2032
... Other Applications), Regions and Company Analysis 2024-2032 Active Pharmaceutical Ingredients Market is envisioned at US$ 212.12 billion in 2023 and is anticipated to attain US$ 377.05 billion via 2032, growing at a CAGR of % ... Read More
-
North America Cardiac Markers Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Reagents and Kits, and Analyzers), Biomarker Type (Troponin, Creatine Kinase-MB, Myoglobin, B-Type Natriuretic Peptide, and Others), Indication (Congestive Heart Failure, Myocradial Infraction, Acute Coronary Syndrome, and Others), End User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing Facilities, and Others), and Country (US, Canada, Mexico)
... Myoglobin, B-Type Natriuretic Peptide, and Others), Indication (Congestive Heart Failure, Myocradial Infraction, Acute Coronary Syndrome, and Others), End User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing Facilities, and Others), and Country (US, Canada, Mexico) The global North ... Read More
-
Cardiac Troponin Market (Troponin Type: Troponin I, Troponin T, and Tropinin C, and Setting: Laboratory Setting and Point-of-Care (POC) Testing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Scope of Report TMR’s report on the global cardiac troponin market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the ... Read More
-
RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033
... By End User: Hospitals; Research Laboratories; Pharmaceutical And Biotechnology CompaniesCovering: Ionis Pharmaceuticals; Alnylam Pharmaceuticals; Sarepta Therapeutics; Jazz Pharmaceuticals; Novartis RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033 from The Business Research ... Read More
Research Assistance
